...
search icon
msle-img

Satellos Bioscience Inc. Common Stock Share Price

MSLE
NMQ
$11.5
+$0.23
(2.04%)
1D

Satellos Bioscience Inc. Common Stock Analyst Forecast

Satellos Bioscience Inc. Common Stock Share Price Chart

Satellos Bioscience Inc. Common Stock Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$237.21M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
162.49K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.52 L
$12.5 H
$11.5

About Satellos Bioscience Inc. Common Stock, Common Stock

Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada. more

Satellos Bioscience Inc. Common Stock Stock Returns

Data is not properly formatted.

Satellos Bioscience Inc. Common Stock Financials

Dec '21Dec '22Dec '23Dec '24
Total Revenue----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue94.05K---[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(94.05K)---[{"date":"2021-12-31","value":-9405264,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses3.69M6.21M11.66M19.38M[{"date":"2021-12-31","value":19.03,"profit":true},{"date":"2022-12-31","value":32.05,"profit":true},{"date":"2023-12-31","value":60.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(3.69M)(6.21M)(11.66M)(19.38M)[{"date":"2021-12-31","value":-368727706,"profit":false},{"date":"2022-12-31","value":-620984380,"profit":false},{"date":"2023-12-31","value":-1165611337,"profit":false},{"date":"2024-12-31","value":-1937583177,"profit":false}]
Total Non-Operating Income/Expense(8.47M)(2.13M)(321.12K)(202.76K)[{"date":"2021-12-31","value":-847382786,"profit":false},{"date":"2022-12-31","value":-212864721,"profit":false},{"date":"2023-12-31","value":-32112167,"profit":false},{"date":"2024-12-31","value":-20276061,"profit":false}]
Pre-Tax Income(12.16M)(8.34M)(11.98M)(19.58M)[{"date":"2021-12-31","value":-1216110492,"profit":false},{"date":"2022-12-31","value":-833849101,"profit":false},{"date":"2023-12-31","value":-1197723504,"profit":false},{"date":"2024-12-31","value":-1957859238,"profit":false}]
Income Taxes----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(12.16M)(8.34M)(11.98M)(19.58M)[{"date":"2021-12-31","value":-1216110492,"profit":false},{"date":"2022-12-31","value":-834217507,"profit":false},{"date":"2023-12-31","value":-1197723504,"profit":false},{"date":"2024-12-31","value":-1957859238,"profit":false}]
Income From Discontinued Operations----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(12.16M)(8.34M)(11.98M)(19.58M)[{"date":"2021-12-31","value":-1216110492,"profit":false},{"date":"2022-12-31","value":-834217507,"profit":false},{"date":"2023-12-31","value":-1197723504,"profit":false},{"date":"2024-12-31","value":-1957859238,"profit":false}]
EPS (Diluted)(6.27)(2.82)(1.62)(2.03)[{"date":"2021-12-31","value":-627.19,"profit":false},{"date":"2022-12-31","value":-281.72,"profit":false},{"date":"2023-12-31","value":-161.73,"profit":false},{"date":"2024-12-31","value":-203.48,"profit":false}]

Satellos Bioscience Inc. Common Stock Ratios

Satellos Bioscience Inc. Common Stock Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

MSLE
Current Ratio 10.70

Satellos Bioscience Inc. Common Stock Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MSLE
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Satellos Bioscience Inc. Common Stock Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MSLE
Debt Ratio Lower is generally better. Negative is bad. 0.09
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.91

Satellos Bioscience Inc. Common Stock Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MSLE
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Satellos Bioscience Inc. Common Stock share price today?

Satellos Bioscience Inc. Common Stock (MSLE) share price today is $11.5

Can Indians buy Satellos Bioscience Inc. Common Stock shares?

Yes, Indians can buy shares of Satellos Bioscience Inc. Common Stock (MSLE) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MSLE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Satellos Bioscience Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Satellos Bioscience Inc. Common Stock (MSLE) via the Vested app. You can start investing in Satellos Bioscience Inc. Common Stock (MSLE) with a minimum investment of $1.

How to invest in Satellos Bioscience Inc. Common Stock shares from India?

You can invest in shares of Satellos Bioscience Inc. Common Stock (MSLE) via Vested in three simple steps:

  • Click on Sign Up or Invest in MSLE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Satellos Bioscience Inc. Common Stock shares
What is Satellos Bioscience Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Satellos Bioscience Inc. Common Stock (MSLE) is $12.5. The 52-week low price of Satellos Bioscience Inc. Common Stock (MSLE) is $4.52.

What is Satellos Bioscience Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Satellos Bioscience Inc. Common Stock (MSLE) is

What is Satellos Bioscience Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Satellos Bioscience Inc. Common Stock (MSLE) is 0.00

What is Satellos Bioscience Inc. Common Stock dividend yield?

The dividend yield of Satellos Bioscience Inc. Common Stock (MSLE) is 0.00%

What is the Market Cap of Satellos Bioscience Inc. Common Stock?

The market capitalization of Satellos Bioscience Inc. Common Stock (MSLE) is $237.21M

What is Satellos Bioscience Inc. Common Stock's stock symbol?

The stock symbol (or ticker) of Satellos Bioscience Inc. Common Stock is MSLE

How Can Investors Use Satellos Bioscience Inc. Common Stock Share Price Data for Long-Term Investment Decisions?

Consider the share price of Satellos Bioscience Inc. Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Satellos Bioscience Inc. Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Satellos Bioscience Inc. Common Stock shares for Indian investors?

When investing in Satellos Bioscience Inc. Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Satellos Bioscience Inc. Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Satellos Bioscience Inc. Common Stock share price with other stocks in the same sector?

Rather than merely checking the share price of Satellos Bioscience Inc. Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Satellos Bioscience Inc. Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top